Immunotherapy harnesses the immune system to target and destroy cancer cells, offering new hope in oncology. This book explores the science behind cancer immunotherapy, including checkpoint inhibitors, CAR-T cell therapy, and cancer vaccines. It discusses the challenges of immune resistance and side effects, providing a balanced perspective on current advances and future directions in cancer treatment.
Naomi Russell is an Associate Professor in the Oncology Department at the University of Health Sciences. She has authored over 150 articles and led numerous clinical trials in cancer immunotherapy. Naomi’s research focuses on enhancing the immune system’s ability to target and eliminate cancer cells. She has served as editor for three influential books on immunotherapy, specializing in immune checkpoint inhibitors and CAR-T cell therapies.